Post-inflammatory modification of colonic afferent mechanosensitivity

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 10, 2009, Pages 1034-1040

  Hughes, P A ^a   Brierley, S M ^a   Blackshaw, L A ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cytokine; Gastrointestinal diseases; Infection inflammation; Irritable bowel syndrome; Neuroimmunology; Pain; Sensory nervous system

Indexed keywords

TRINITROBENZENESULFONIC ACID;

CAMPYLOBACTER; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; IRRITABLE COLON; NEUROIMMUNOLOGY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POST INFECTIOUS IRRITABLE BOWEL SYNDROME; QUALITY OF LIFE; REVIEW; SALMONELLA; TH1 CELL; VISCERAL PAIN;

ANIMALS; COLITIS; COLON; GASTROINTESTINAL MOTILITY; HUMANS; INFLAMMATION; IRRITABLE BOWEL SYNDROME; MECHANOTRANSDUCTION, CELLULAR; VISCERAL AFFERENTS;

EID: 72449210563     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05248.x     Document Type: Review

References (81)

1. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: Review and what's new. Rev. Gastroenterol. Disord. 2001; 1:2-17.
2. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
3. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131 (Pubitemid 35408332)
4. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-934
5. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45 (Suppl. II): 11-25-30. (Pubitemid 29434809)
6. Gralnek IM., Hays RD, Kilboume A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654-660 (Pubitemid 30681124)
7. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 125-32.
8. Blackshaw LA, Gebhart GF. The pharmacology of gastrointestinal nociceptive pathways. Curr. Opin. Pharmacol. 2002; 2: 642-9.
9. Brierley SM, Jones CR III, Xu W et al. Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice. J. Physiol. 2005; 567: 267-281
10. Brierley SM, Jones RC III, Gebhart GF, Blackshaw LA. Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology 2004; 127:166-178
11. Brierley SM, Jones RC III, Xu L, Gebhart GF, Blackshaw LA. Activation of splanchnic and pelvic colonic afferents by bradykinin in mice. Neurogastroenterol. Motil. 2005; 17: 854-862
12. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-920 (Pubitemid 46440872)
13. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: A six year follow up study. Gut 2002; 51: 410-413 (Pubitemid 34907711)
14. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome. Postal survey of patients. BMJ 1997; 314: 779-782 (Pubitemid 27117047)
15. Spiller RC. Irritable bowel syndrome. Br. Med. Bull. 2004; 72:15-29.
16. Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q. J. Med. 1962; 31: 307-322
17. Stewart GT. Post-dysenteric colitis. BMJ 1950; 1:405-409
18. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-153 (Pubitemid 26025154)
19. McKendrick MW, Read NW. Irritable bowel syndrome: Post salmonella infection. J. Infect. 1994; 29:1-3. (Pubitemid 24243103)
20. Spiller RC. Role of infection in irritable bowel syndrome. J. Gastroenterol. 2007; 42 (Suppl. 17): 41-47 (Pubitemid 46140363)
21. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-1659 (Pubitemid 37500429)
22. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am. J Gastroenterol. 2003; 98:1578-1583 (Pubitemid 36875351)
23. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811
24. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702. (Pubitemid 38298317)
25. Yu PL, Fujimura M, Okumiya K, Kinoshita M, Hasegawa H, Fujimiya M. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J. Comp. Neurol. 1999; 411: 654-665 (Pubitemid 29368195)
26. Bertrand PP. Real-time measurement of serotonin release and motility in guinea pig ileum. J. Physiol. 2006; 577: 689-704.
27. Greenwood-van Meerveld B. Importance of 5-hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity. Neurogastroenterol. Motil. 2007; 19 (Suppl. 2): 13-18.
28. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: Alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol. Motil. 2007; 19(Suppl. 2): 25-31. (Pubitemid 47037963)
29. Dinan TG, Quigley EM, Ahmed SM. et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 2006; 130: 304-311
30. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-551 (Pubitemid 40585355)
31. van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am. J. Gastroenterol. 2005;100:2510-2516
32. Hughes PA, Brierley SM, Martin CM et al. TRPVl-expressing sensory fibres and IBS. Links with immune function, Gut 2009; 58: 465-466
33. Stein C, Schafer M, Machelska H. Attacking pain at its source: New perspectives on opioids. Nat. Med. 2003; 9: 1003-1008 (Pubitemid 37021779)
34. + T-cell modulation of visceral nociception in mice. Gastroenterology 2006; 130: 1721-1728
35. Binshtok AM, Wang H, Zimmermann. K et al. Nociceptors are interleukin-lbeta sensors. J. Neurosci. 2008; 28: 14062-14073
36. Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-lbeta in the rat. Brain Res. 1994; 657: 133-140 (Pubitemid 24281257)
37. Jin X, Gereau RW 4th, Acute p38-mediated modulation of tetrodotoxinresistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J. Neurosci. 2006; 26:246-255 (Pubitemid 43089538)
38. Liu L, Yang TM, Liedtke W, Simon SA. Chronic IL-Ibeta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J. Neurophysiol 2006; 95: 1478-1490
39. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 2006; 51: 240-264 (Pubitemid 43902971)
40. Obreja O, Rathee PK, Lips KS, Distler C, Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons. Involvement of IL-IRI, tyrosine kinase, and protein kinase C. FASEB J. 2002; 16: 1497-1503 (Pubitemid 35154632)
41. Schafers M, Lee DH, Brors D, Yaksh TL, Sorkin LS. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J. Neurosci, 2003; 23: 3028-3038 (Pubitemid 36418639)
42. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 2004; 361:184-187 (Pubitemid 38609247)
43. Scholz J. Woolf CJ. The neuropathic pain triad. Neurons, immune cells and glia. Nat. Neurosci. 2007; 10: 1361-1368 (Pubitemid 350014681)
44. Boisse L, Chisholm S, Lukewich M, Lomax A, Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease. Clin. Exp. Pharmacol. Physiol. 2009; 36:1026-1033
45. Zenewicz LA, Antov A, Flavell RA. CD4 T-cell differention and inflammatory bowel disease. Trends MoI. Med. 2009;15:199-207.
46. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: Physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. 1988; 450:153-169
47. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 2006; 130: 1421-1434
48. Fioramonti J, Gebhart GF. In vivo and transgenic animal models used to study visceral hypersensitivity. Neurogastroenterol. Motil. 2007; 19 (Suppl): 20-28 (Pubitemid 46058980)
49. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: From animal models to drug development. Gut 2008; 57: 384-404. (Pubitemid 351288106)
50. Jones RC III, Otsuka E, Wagstrom E, Jensen CS, Price MP, Gebhart GF. Short-term sensitization of colon mechanoreceptors is associated with long-term hypersensitivity to colon distention in the mouse. Gastroenterology 2007; 133: 184-194
51. Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007; 132:615-627 (Pubitemid 46274656)
52. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003; 3: 521-533 (Pubitemid 37328672)
53. Bercik P, Wang L, Verdu EF et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004; 127: 179-187 (Pubitemid 38962286)
54. Gschossmann JM, Liebregts T, Adam B et al. Long-term effects of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension. Dig. Dis. Sci. 2004; 49: 96-101. (Pubitemid 38183752)
55. Hughes PA, Brierley SM, Martin CM, Brookes SJH, Linden DR, Blackshaw LA. Post-inflammatory colonic afferent sensitization: Different subtypes, different pathways, and different time courses. Gut 2009. Epub 25 March. 2009; doi: 10.1136/gut.2008. 170811
56. Keating C, Beyak M, Foley S et al. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: Role of altered serotonin metabolism. J. Physiol. 2008; 586:4517-4530
57. Lamb K, Zhong F, Gebhart GF, Bielefeldt K. Experimental colitis in mice and sensitization of converging visceral and somatic afferent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: G451-7.
58. Aerssens J, Hillsley K, Peeters PJ et al. Alterations in the brain-gut axis underlying visceral chemosensitivity in Nippostrongyhis brasiliensisinfected miee. Gastroenterology 2007; 132: 1375-1387 (Pubitemid 46627585)
59. Coldwell JR, Phillis BD, Sutherland K, Howarth GS, Blackshaw LA. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J. Physiol. 2007; 579: 203-213 (Pubitemid 46243406)
60. Larsson MH, Rapp L, Lindstrom E. Effect of DSS-induced colitis on visceral sensitivity to colorectal distension in mice. Neurogastroenterol. Motil. 2006; 18:144-152
61. + currents in mouse colonic dorsal root ganglia neurons and their role in colitis-induced hyperexcitability. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 287: G845-55.
62. De Schepper HU, De Winter BY, Van Nassauw L et al. TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats. J. Physiol. 2008; 586: 5247-5258
63. Lynn. PA, Chen BN, Zagorodnyuk. VP, Costa M, Brookes SJ. TNBSinduced inflammation modulates the function of one class of lowthreshold rectal mechanoreceptors in the guinea pig. Am. J. Physiol. Gastrointest. Liver Physiol. 2008; 295: 0862-871
64. MeCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999; 45: 864-873
65. Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta JN. The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 2007; 148:1021-1032 (Pubitemid 47419190)
66. Simpson J, Sundler F, Humes DJ et al. Prolonged elevation of galanin and tachykinin, expression in mucosal and myenteric enteric nerves in. trinitrobenzene sulphonic acid colitis. Neurogastroenterol. Motil. 2008; 20: 392-406.
67. Linden DR, Couvrette JM, Ciolino A et al. Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon. Neurogastroenterol. Motil. 2005; 17: 751-760 (Pubitemid 41400725)
68. Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, Naumann M. Inhibition, of RICK/nuctear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J. Biol. Chem. 2005; 280:14981-14988 (Pubitemid 40562850)
69. Bouma G, Kaushiva A, Strober W. Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 2002; 123: 554-565 (Pubitemid 34827199)
70. Scheiffele F, Fuss IJ. Induction of TNBS colitis in mice. Curr. Protoc. Immunol. 2002; 459: 15-19.
71. Adam B, Liebregts T, Gschossmann JM et al. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model Pain 2006; 123:179-186 (Pubitemid 43816772)
72. Yang J, Li Y, Zuo X, Zhen Y, Yu Y, Gao L. Transient receptor potential ankyrin-1 participates in visceral hyperalgesia following experimental colitis. Neurosci. Lett 2008; 440: 237-241,
73. Wynn G, Ma B, Ruan HZ, Bumstock G. Purinergic component of mechanosensory transduction is increased in a rat model of colitis. Am. J. Physiol. Gastrointest Liver Physiol. 2004; 287: G647-57. (Pubitemid 39096632)
74. Adam B, Liebregts T, Best J et al. A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model. Scand. J. Gastroenterol. 2006; 41: 155-160 (Pubitemid 43247197)
75. Liebregts T, Adam B, Bertel A et al. Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model. Neurogastroenterol. Motil. 2005; 17:410-414
76. Zhou Q, Price DD, Caudle RM, Verne GN. Visceral and somatic hypersensitivity in TNBS-induced colitis in rats. Dig. Dis. Sci. 2008; 53:429-435 (Pubitemid 351170021)
77. Brierley SM, Page AJ, Hughes PA et al. Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology 2008; 134: 2059-2069.
78. Song X, Chen BN, Zagorodnyuk VP et al. Identification of medium/ high threshold extrinsic mechanosensitive afferent nerves to the gastrointestinal tract. Gastroenterology 2009; 137: 274-284.
79. Page AJ, O'Donnell TA, Cooper NJ, Young RL, Blackshaw LA. Nitric oxide as an endogenous peripheral modulator of visceral sensory neuronal, function. J. Neurosci. 2009; 29: 7246-7255.
80. Brierley SM, Hughes PA, Page AJ et al. The ion channel TRPAl is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology 2009; doi: 10.1053/j.gastro.2009.07.048.
81. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Clin. Gastroenterol. Hepatol. 2008; 6: 545-555.